Cover Image


View/Hide Left Panel

Kaplan, M.H. 1963. Immunologic relation of streptococcal and tissue antigens. I. Properties of an antigen in certain strains of group A streptococci exhibiting an immunologic cross-reaction with human heart tissue. J. Immunol. 90:595–606.

Lancefield, R.C. 1962. Current knowledge of type-specific M antigens of group A streptococcus. J. Immunol. 89:307–313.

Lancet. 1985. Decline in rheumatic fever. Lancet II:647–648.

Land, M.A., and A.L.Bisno. 1983. Acute rheumatic fever. A vanishing disease in suburbia. JAMA 249(7):895–898.

Manjula, B.N., and V.A.Fischetti. 1980a. Studies on group A streptococcal M-proteins: Purification of type 5 M-protein and comparison of its amino terminal sequence with two immunogenically unrelated M-protein molecules. J. Immunol. 124(1):261–267.

Manjula, B.N., and V.A.Fischetti. 1980b. Tropomyosin-like seven residue periodicity in three immunogenically distinct streptococcal M proteins and its implication for the antiphagocytic property of the molecule. J. Exp. Med. 151(3):695–707.

Manjula, B.N., A.S.Acharya, S.M.Mische, T.Fairwell, and V.A. Fischetti. 1984. The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J. Biol. Chem. 259(6):3686–3693.

Markowitz, M. 1981. Observations on the epidemiology and preventability of rheumatic fever in developing countries. Clin. Ther. 4:240–251.

Merrifield, R.B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149–2155.

National Institute of Allergy and Infectious Diseases. 1985. Program on Accelerated Development of New Vaccines. Progress Report. Bethesda, Md.: National Institutes of Health.

Phillips, G.N., P.F.Flicker, C.Cohen, B.N.Manjula, and V.A. Fischetti. 1982. Streptococcal M protein: Alpha-helical coiled-coil structure and arrangement on the cell surface. Proc. Natl. Acad. Sci. USA 78(8):4689–4693.

Quinn, R.W. 1982. Streptococcal infections. Pp. 525–552 in Bacterial Infections of Human, A.S.Evans and H.A.Feldman, eds. New York: Plenum.

Quinn, R.W., and C.F.Federspiel. 1974. The incidence of rheumatic fever in metropolitan Nashville, 1963–1969. Am. J. Epidemiol. 99:273–280.

Russell, H., and R.R.Facklam. 1975. Guanidine extraction of streptococcal M proteins. Infect. Immun. 12(3):679–686.

Stollerman, G.H. 1975. Rheumatic Fever and Streptococcal Infection. New York: Grune and Stratton.

Vosti, K.L., and W.K.Williams. 1978. Extraction of streptococcal type 12 M protein by cyanogen bromide. Infect. Immun. 21(2):546–555.

Whitnack, E., and A.L.Bisno. 1980. Rheumatic fever and other immunologically mediated cardiac diseases. Pp. 894–929 in Clinical Immunology, Vol. 2, C.W.Parker, ed. Philadelphia: W.B.Saunders.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement